Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
01/16/2026 | PUT | $97.50 | 649 | +160 | +32.72% |
01/16/2026 | PUT | $100.00 | 1,030 | +150 | +17.05% |
01/15/2027 | PUT | $100.00 | 1,196 | +115 | +10.64% |
08/15/2025 | PUT | $115.00 | 27 | +26 | +2,600.00% |
01/15/2027 | CALL | $130.00 | 120 | +24 | +25.00% |
01/16/2026 | CALL | $135.00 | 793 | +19 | +2.45% |
01/16/2026 | PUT | $155.00 | 0 | 0 | |
07/18/2025 | CALL | $115.00 | 1,606 | -1 | -0.06% |
07/18/2025 | CALL | $120.00 | 2,213 | -1 | -0.05% |
10/17/2025 | PUT | $105.00 | 432 | -1 | -0.23% |
07/18/2025 | CALL | $110.00 | 811 | -2 | -0.25% |
07/18/2025 | PUT | $115.00 | 1,116 | -13 | -1.15% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Dodge & Cox Stock Fund | 0.65% | 14.91M | 1.46B |
Vanguard/Primecap Fund | 0.46% | 10.44M | 1.02B |
Loomis Sayles Growth Fund | 0.11% | 2.61M | 255.02M |
Franklin Mutual Series Fund-Mutual Global Discovery Fund | 0.10% | 2.34M | 228.17M |
Vanguard Horizon Fund-Capital Opportunity Fund | 0.10% | 2.28M | 222.47M |
Principal Equity Income Fd | 0.10% | 2.22M | 216.7M |
Hartford Dividend & Growth Fund | 0.09% | 2.08M | 203.09M |
Franklin Mutual Series Fund-Mutual Shares Fund | 0.08% | 1.72M | 168.16M |
Vanguard Fenway Fds-Primecap Core Fund | 0.07% | 1.7M | 166.51M |
DFA International Value Series | 0.07% | 1.6M | 155.93M |
ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen
06/21 06:20 am
GlobeNewswire Inc.
Read moreICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients
06/21 06:20 am
GlobeNewswire Inc.
Read morePress Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
06/15 11:22 am
GlobeNewswire Inc.
Read moreGiant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight
06/12 01:00 pm
GlobeNewswire Inc.
Read moreNovartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH
06/12 02:00 am
GlobeNewswire Inc.
Read moreRheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies
06/10 04:53 am
GlobeNewswire Inc.
Read moreNovartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
06/02 01:15 am
GlobeNewswire Inc.
Read moreNovartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
06/01 09:00 am
GlobeNewswire Inc.
Read moreThe World Market for Smoking Cessation & Nicotine De-Addiction Products 2025-2030: Precision Counseling, Targeted Pharmacogenomic Therapies, and Resilient Supply Chains Present Lucrative Opportunities
05/30 04:56 am
GlobeNewswire Inc.
Read moreGlobal Smart Inhalers Market to Observe Impressive Growth at a CAGR of ~21% by 2032 | DelveInsight
05/29 01:00 pm
GlobeNewswire Inc.
Read morePenicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:58 am
GlobeNewswire Inc.
Read moreDrug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities
05/29 05:42 am
GlobeNewswire Inc.
Read moreSchizophrenia Drugs Market Research Report 2025-2035: Advances in Antipsychotic Drug Development, Increasing Prevalence, & Greater Awareness and Access to Mental Health Care Bolster Growth
05/27 10:56 am
GlobeNewswire Inc.
Read moreAplastic Anemia Global Clinical Trials Review, 2025 | Explore Trends and Enrollment Data in Aplastic Anemia Clinical Trials
05/20 06:59 am
GlobeNewswire Inc.
Read moreSaudi Arabia Active Pharmaceutical Ingredients Market Forecasts & Opportunities Report 2024-2025 & 2030 Featuring Pfizer, Aurobindo Pharma, Novartis, BASF, Viatris, and Novo Nordisk
05/13 04:59 am
GlobeNewswire Inc.
Read moreSaudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis
05/13 04:46 am
GlobeNewswire Inc.
Read moreContract Research and Manufacturing Services (CRAMS) Business Report 2025: Market to Reach $211.4 Billion by 2030, Fueled by Growing Demand for Biologics and Biosimilars
05/08 10:55 am
GlobeNewswire Inc.
Read moreGeneric Oncology Drugs Market Size Estimated to Reach USD 30,998 Mn by 2034, Rising Global Cancer Cases Increase Demand for Affordable Treatments
05/07 11:00 am
GlobeNewswire Inc.
Read moreLiver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®
05/02 10:00 am
GlobeNewswire Inc.
Read moreMetastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
04/30 01:00 pm
GlobeNewswire Inc.
Read moreNovartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
04/30 11:22 am
Benzinga
Read moreNovartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance
04/29 12:39 pm
Benzinga
Read moreThese 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
04/26 10:15 am
The Motley Fool
Read moreRoche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
04/22 03:21 pm
Benzinga
Read moreGastric Neuroendocrine Tumors Market Report 2025 | Advancements in Diagnostics Propel Early Detection of gNETs
04/21 06:49 am
GlobeNewswire Inc.
Read moreHuntington's Disease Treatment Market to Hit $2.03 Billion by 2033, Driven by Cutting-Edge Therapies
04/18 04:28 am
GlobeNewswire Inc.
Read moreAtopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market
04/18 04:26 am
GlobeNewswire Inc.
Read moreNovartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
04/11 09:36 am
Benzinga
Read moreGlobal Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight
04/10 01:00 pm
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read moreOphthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities
04/08 04:52 am
GlobeNewswire Inc.
Read moreNovartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)
04/02 08:13 pm
GlobeNewswire Inc.
Read moreWhy Pfizer Is My Largest Healthcare Position
03/27 06:45 am
The Motley Fool
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read moreFDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease
03/21 11:36 am
Benzinga
Read moreNovartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
03/19 01:09 pm
Benzinga
Read moreBioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - Report by Transparency Market Research, Inc.
03/13 06:00 pm
GlobeNewswire Inc.
Read moreComplement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030
03/12 11:50 am
GlobeNewswire Inc.
Read moreIpsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
03/12 02:28 am
GlobeNewswire Inc.
Read moreCancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection
03/06 05:55 am
GlobeNewswire Inc.
Read moreCAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
03/05 02:00 pm
GlobeNewswire Inc.
Read more3 Dividend Stocks That Are No-Brainer Buys Right Now
03/01 06:51 am
The Motley Fool
Read moreNovartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)
02/28 10:00 am
GlobeNewswire Inc.
Read moreTALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight
02/24 02:00 pm
GlobeNewswire Inc.
Read moreNHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
02/24 01:39 pm
Benzinga
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read moreEvolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight
02/21 02:00 pm
GlobeNewswire Inc.
Read moreHyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034
02/21 11:00 am
GlobeNewswire Inc.
Read moreBESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
02/20 02:00 pm
GlobeNewswire Inc.
Read more